Back to results
US 8,946,301 B2Granted
Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis
AssigneeALS Therapy Development Institute
InventorsSteven Perrin, John Lincecum, Alan Gill, Fernando Vieira
Life of this patent
Estimating the term…
Abstract
Methods and therapeutic compositions are disclosed for treating neurodegenerative disorders and, in particular Amyotrophic Lateral Sclerosis, using sphingosine1-phosphate receptor modulators, such as fingolimod or a pharmaceutically acceptable salt, hydrate, or solvate thereof.
Claims13
A method of treating Amyotrophic Lateral Sclerosis (ALS) comprising:
- administering a compound to a subject having ALS, wherein the compound is
- or a pharmaceutically acceptable salt, hydrate, or solvate thereof.
Dependencies are inferred from the claim text.